Back to School for a Wedding

Chiedza Mushayamunda and Matthew Hooker went through “a range of emotions,” as Mr. Hooker put it, when they realized their long-planned May 30 wedding would have to be severely downsized because of the coronavirus. The wedding was to have taken place at the Millennium Center in Winston-Salem, N.C, with more than 200 guests, including family…

Quenching an Ache to Celebrate

Morgan Clark walked into the bedroom of his fiancé, Elizabeth Reilly, on March 18 and found her sobbing. The devastating effects of the coronavirus forced the couple to move their originally scheduled wedding date up to March 22, from May 8. And they had to change the location of the church, from the Incarnation Anglican…

Buckeyes Through and Through

Mary Noelle Guido and Nicholas Raymond McMurray realized they were Buckeyes through and through when they met in 2014 at a rooftop party in Washington. They grew up 30 minutes from each other in Ohio — she in Brecksville and he in Euclid — and both graduated from Ohio State cum laude. He also went…

The Wrong Message, but the Right Guy

The very misstep that everyone in the electronic age perhaps fears most — sending a message to the wrong recipient — is what brought Victoria Herrmann and Eli Keene together. Both were working at the Carnegie Endowment for International Peace, which is based in Washington. She was a junior fellow in the energy program, focused…

A Zoom Wedding With a Salute to Sweden

Caitlin Ashley DiLena’s exposure to anything Swedish was once limited to trips to Ikea, the Swedish Chef muppet character, and the Swedish princess cake segment on “The Great British Baking Show.” This was before she matched with Nicklas Alexander Ansman Giertz on Tinder in May 2018, and then met him a couple of weeks later…

Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43. The trial did find a statistically non-significant, modest (19%) reduction in…